Dr. Dan Sperling As a radiologist specializing in prostate cancer diagnosis and treatment, I’m writing to share a fear I often hear from my patients. “Will this treatment affect my sex life?” This ...

The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.

A recent study suggests that using artificial intelligence to measure tumor size could reduce treatment failures by more than 70%.

Monte Rosa Therapeutics' stock falls as MRT-2359 faces challenges in targeting CRPC. Click here to read an analysis of GLUE stock now.

The MR-LINAC system enhances adaptive treatment planning by generating a new image set before each treatment, accounting for ...

Gary A. Ulaner, M.D., Ph.D., F.A.C.N.M. is the director of molecular imaging and therapy at Hoag Family Cancer Institute and ...

Bean Chapman is a policy analyst and committee chair for Knox, Anderson and Blount counties for the Tennessee Equality ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the fourth ...

Vicero, Inc., a preclinical-stage biopharmaceutical company developing next-generation VINCOBODIES for immune-mediated diseases, today announced the appointment of two distinguished oncologists and ...

Trump administration efforts to shave about 1 in 6 Veterans Affairs jobs have hit Pittsburgh. Is it about cutting waste or privatization?

Researchers from around the U.K., led by the University of Oxford, have found that a new way of performing prostate biopsies ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...